Scarica l'app Stockscreener
426.75
0.66%
2.785
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$423.96
Aprire:
$423
Volume 24 ore:
269.49K
Relative Volume:
0.14
Capitalizzazione di mercato:
$150.76B
Reddito:
$11.03B
Utile/perdita netta:
$3.16B
Rapporto P/E:
48.91
EPS:
8.7251
Flusso di cassa netto:
$3.22B
1 W Prestazione:
+4.99%
1M Prestazione:
+15.60%
6M Prestazione:
-5.30%
1 anno Prestazione:
-0.66%
Intervallo 1D:
$421.03
$427.45
Intervallo di 1 settimana:
$402.00
$427.53
Portata 52W:
$328.57
$603.88
Intuitive Surgical Inc Stock (ISRG) Company Profile
Nome
Intuitive Surgical Inc
Settore
Industria
Telefono
(408) 523-2100
Indirizzo
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, RMD, MDLN, ALC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
426.75 | 150.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
185.70 | 50.58B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
232.04 | 32.63B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.19 | 31.75B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.12 | 31.00B | 10.63B | 819.00M | 1.59B | 1.6577 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-07 | Iniziato | Barclays | Overweight |
| 2026-08-12 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2026-07-30 | Downgrade | HSBC Securities | Buy → Hold |
| 2026-07-28 | Iniziato | UBS | Buy |
| 2026-07-09 | Iniziato | BMO Capital Markets | Outperform |
| 2026-03-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2026-01-27 | Iniziato | TD Cowen | Buy |
| 2025-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-07-23 | Downgrade | Erste Group | Buy → Hold |
| 2025-06-09 | Downgrade | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Reiterato | Citigroup | Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-11-17 | Iniziato | HSBC Securities | Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-19 | Reiterato | BTIG Research | Buy |
| 2023-04-19 | Reiterato | BofA Securities | Buy |
| 2023-04-19 | Reiterato | Citigroup | Buy |
| 2023-04-19 | Reiterato | Evercore ISI | In-line |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-19 | Reiterato | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-19 | Reiterato | Raymond James | Outperform |
| 2023-04-19 | Reiterato | Stifel | Buy |
| 2023-04-19 | Reiterato | Truist | Buy |
| 2023-04-19 | Reiterato | Wells Fargo | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-23 | Iniziato | William Blair | Outperform |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Neutral |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Downgrade | Redburn | Buy → Neutral |
| 2022-01-21 | Reiterato | BTIG Research | Buy |
| 2022-01-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-21 | Reiterato | Deutsche Bank | Hold |
| 2022-01-21 | Reiterato | Evercore ISI | In-line |
| 2022-01-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Reiterato | Piper Sandler | Neutral |
| 2022-01-21 | Reiterato | Raymond James | Outperform |
| 2022-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2022-01-21 | Reiterato | Stifel | Buy |
| 2022-01-21 | Reiterato | UBS | Neutral |
| 2022-01-21 | Reiterato | Wells Fargo | Overweight |
| 2022-01-10 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2021-07-21 | Reiterato | BofA Securities | Neutral |
| 2021-07-21 | Reiterato | Citigroup | Buy |
| 2021-07-21 | Reiterato | JP Morgan | Overweight |
| 2021-07-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Reiterato | Piper Sandler | Neutral |
| 2021-07-21 | Reiterato | SVB Leerink | Mkt Perform |
| 2021-07-21 | Reiterato | Stifel | Buy |
| 2021-07-21 | Reiterato | UBS | Neutral |
| 2021-07-21 | Reiterato | Wells Fargo | Overweight |
| 2021-07-14 | Reiterato | Goldman | Buy |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Iniziato | Citigroup | Buy |
| 2020-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Iniziato | Argus | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-07-20 | Reiterato | Bernstein | Outperform |
| 2020-04-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Downgrade | CFRA | Hold → Sell |
| 2020-04-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Downgrade | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Reiterato | Wells Fargo | Outperform |
| 2019-11-21 | Iniziato | Oppenheimer | Perform |
| 2019-07-19 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-22 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-02 | Iniziato | Deutsche Bank | Buy |
| 2018-10-31 | Reiterato | Piper Jaffray | Overweight |
| 2018-10-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
Mostra tutto
Intuitive Surgical Inc Borsa (ISRG) Ultime notizie
Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider - Zacks Investment Research
Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect - The Motley Fool
Intuitive Surgical Inc. Advanced Charts | ISRG - Barron's
Intuitive Surgical (NASDAQ:ISRG) Combines Strong Growth With a Constructive Technical Setup - ChartMill
Should Barclays’ Bullish Initiation Amid Rising Rivalry Require Action From Intuitive Surgical (ISRG) Investors? - Yahoo! Finance Canada
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know - Zacks Investment Research
Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise? - Zacks Investment Research
Jim Cramer Has Soured on Intuitive Surgical (ISRG). The Reason is Johnson & Johnson - Yahoo Finance
Intuitive Surgical (XBUL:IUI1) 5-Year RORE % : 0.00% (As of Jun. 2026) - GuruFocus
Intuitive Surgical Inc. Research & Ratings | ISRG - Barron's
Intuitive Surgical: The Multiple Fell, The Story Didn't (NASDAQ:ISRG) - Seeking Alpha
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - Zacks Investment Research
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - TradingView
A Look at Intuitive Surgical Inc (ISRG) After 3.8% Gain -- GF Va - GuruFocus
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive Surgical Inc. Stock Grades | ISRG - Barron's
Intuitive Surgical Inc Stock (ISRG) Moved Up by 3.02% on Oct 5: Key Drivers Unveiled - TradingKey
What Do Fresh European Clearances Mean for Intuitive Surgical (NASDAQ:ISRG)? - Kalkine Media
Intuitive Surgical Inc. Research & Ratings | ISRG - Barron's
Intuitive Surgical: A Surgical Leader Facing A Valuation Problem (NASDAQ:ISRG) - Seeking Alpha
Intuitive Surgical (ISRG): Is Its Robotic-Surgery Moat Still Untouchable? - Yahoo Finance
Intuitive Surgical Inc. stock underperforms Friday when compared to competitors - marketwatch.com
Intuitive Surgical: The 17% Selloff Is A Buy (NASDAQ:ISRG) - Seeking Alpha
Can ISRG Offset China Weakness With Expansion in India and Japan? - Zacks Investment Research
Intuitive Surgical: Strong Growth, But Valuation Comes At A Premium - Seeking Alpha
Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors - marketwatch.com
Is Wall Street Dead Wrong About Intuitive Surgical? Here's My Honest Answer. - Yahoo Finance
Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors - marketwatch.com
10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises - Zacks Investment Research
Top Stock Reports for Visa, Intuitive Surgical & Williams Companies - Zacks Investment Research
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Zacks Investment Research
Intuitive Surgical stock trades at EUR 364.65 before October 20 results - AD HOC NEWS
Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? - Yahoo Finance
Intuitive Surgical stock last trades at USD 414.55 on September 28, 2026 - AD HOC NEWS
Intuitive Surgical, Inc. (ISRG) Options ChainYahoo Finance - Yahoo! Finance Canada
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's How Much $1000 Invested In Intuitive Surgical 10 Years Ago Would Be Worth Today - Benzinga
Intuitive Surgical Stock Has Plunged 29% This Year. Is the Market Overreacting? - Yahoo Finance
Intuitive Surgical Stock Has Plunged 29% This Year. Is the Market Overreacting? - The Globe and Mail
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - Zacks Investment Research
Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx - Zacks Investment Research
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Zacks Investment Research
Sunnyvale tech firm accused of axing worker for reporting sexual harassment - The Mercury News
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now? - TradingView
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now - Yahoo Finance UK
2 Beaten-Down Stocks to Buy Before They Bounce Back - The Motley Fool
Why Intuitive Surgical (ISRG) Is Up 6.5% After New da Vinci SP Transvaginal Approval – And What's Next - Yahoo Finance
Intuitive Surgical stock heads into the open after a 2.3 percent fall - AD HOC NEWS
Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Intuitive Surgical Inc Azioni (ISRG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Widman Fredrik | VP Corporate Controller |
Sep 15 '26 |
Sale |
374.44 |
1,089 |
407,765 |
1,026 |
| FREDRIK WIDMAN | Officer |
Sep 15 '26 |
Proposed Sale |
377.94 |
2,178 |
823,153 |
0 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Sep 11 '26 |
Sale |
365.79 |
25 |
9,145 |
764 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Sep 10 '26 |
Sale |
347.66 |
23 |
7,996 |
789 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Sep 09 '26 |
Sale |
350.20 |
23 |
8,055 |
812 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Sep 08 '26 |
Sale |
361.23 |
46 |
16,617 |
835 |
| MARK BROSIUS | Officer |
Sep 08 '26 |
Proposed Sale |
366.70 |
694 |
254,490 |
0 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Aug 21 '26 |
Sale |
375.57 |
77 |
28,919 |
881 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Aug 20 '26 |
Sale |
396.37 |
77 |
30,520 |
958 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Aug 19 '26 |
Sale |
394.26 |
77 |
30,358 |
1,035 |
1.06%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):